Genvor Incorporated

Genvor Incorporated is a biotechnology company that leverages AI-accelerated peptide discovery to develop high-performance solutions for sustainable agriculture and human health and wellness. Headquartered in Henderson, Nevada, the company's mission is to boost crop yields, reduce reliance on chemical inputs, and contribute to a sustainable food future, while simultaneously bringing science-backed peptide innovations to the human health sector.

The company's core offerings include patented and proprietary peptides designed to provide crops with anti-pathogen and enhanced nutritional properties. These peptides are developed using their proprietary BioCypher Algorithm, which integrates computational biology, machine learning, and regulatory benchmarks. Genvor's agricultural solutions can be applied as biological foliar treatments or integrated as transgenic seed traits. Beyond agriculture, the company applies its peptide platform to create targeted solutions for consumer recovery, performance, anti-aging, and daily wellness.

In recent news, Genvor announced a strategic Memorandum of Understanding with Canlab International™ in April 2026 to advance its commercial peptide pipeline. The company also expanded its corporate strategy into the human health and wellness market in March 2026, leveraging its BioCypher platform for consumer peptide solutions. Genvor's AGM182 antifungal peptide technology received validation through a peer-reviewed publication in February 2026. The company operates with a licensing-first model in agriculture and a direct-to-consumer strategy for human health and wellness products. Chad Pawlak Sr. serves as the CEO, with co-founders Dr. Jesse Jaynes and Dr. Clayton Yates leading scientific development.